Section of Stem Cell Biology, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands.
Ann N Y Acad Sci. 2020 Apr;1466(1):24-38. doi: 10.1111/nyas.14059. Epub 2019 Apr 21.
Peripheral blood hematopoietic stem and progenitor cells (HSPCs), mobilized by granulocyte colony-stimulating factor, are widely used as a source for both autologous and allogeneic stem cell transplantation. The use of mobilized HSPCs has several advantages over traditional bone marrow-derived HSPCs, including a less invasive harvesting process for the donor, higher HSPC yields, and faster hematopoietic reconstitution in the recipient. For years, the mechanisms by which cytokines and other agents mobilize HSPCs from the bone marrow were not fully understood. The field of stem cell mobilization research has advanced significantly over the past decade, with major breakthroughs in the elucidation of the complex mechanisms that underlie stem cell mobilization. In this review, we provide an overview of the events that underlie HSPC mobilization and address the relevant cellular and molecular components of the bone marrow niche. Furthermore, current and future mobilizing agents will be discussed.
外周血造血干细胞和祖细胞(HSPCs)在粒细胞集落刺激因子的作用下被动员,被广泛用作自体和异基因干细胞移植的来源。与传统的骨髓来源的 HSPC 相比,动员的 HSPCs 具有几个优点,包括对供体的采集过程侵入性较小、HSPC 产量更高,以及受体更快的造血重建。多年来,细胞因子和其他药物动员 HSPCs 离开骨髓的机制尚未完全阐明。过去十年中,干细胞动员研究领域取得了重大进展,阐明了干细胞动员所涉及的复杂机制方面取得了重大突破。在这篇综述中,我们概述了支持 HSPC 动员的事件,并探讨了骨髓龛的相关细胞和分子成分。此外,还讨论了当前和未来的动员剂。